Coastline Trust Co decreased its position in Clorox Co (NYSE:CLX) by 8.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,545 shares of the company’s stock after selling 400 shares during the period. Coastline Trust Co’s holdings in Clorox were worth $599,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Janus Henderson Group PLC increased its stake in shares of Clorox by 8,008.5% during the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after purchasing an additional 1,307,153 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Clorox by 2.6% during the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after purchasing an additional 369,918 shares in the last quarter. APG Asset Management N.V. increased its stake in shares of Clorox by 30.9% during the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock worth $171,736,000 after purchasing an additional 307,700 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of Clorox by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after purchasing an additional 265,200 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of Clorox by 24.5% during the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after purchasing an additional 263,700 shares in the last quarter. 73.42% of the stock is owned by institutional investors.

A number of analysts have recently commented on the stock. Jefferies Group reissued a “hold” rating and set a $130.00 target price on shares of Clorox in a research note on Wednesday. Wells Fargo & Company restated a “hold” rating and set a $130.00 price target on shares of Clorox in a research report on Wednesday. Deutsche Bank began coverage on shares of Clorox in a research report on Wednesday. They set a “hold” rating and a $142.00 price target on the stock. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a research report on Friday, November 10th. Finally, Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $129.05.

In other news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the sale, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the sale, the senior vice president now directly owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by insiders.

Clorox Co (NYSE:CLX) opened at $146.26 on Friday. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. The firm has a market cap of $18,903.69, a PE ratio of 26.42, a price-to-earnings-growth ratio of 3.99 and a beta of 0.43. Clorox Co has a fifty-two week low of $115.00 and a fifty-two week high of $147.38.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. Clorox’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.36 EPS. equities research analysts predict that Clorox Co will post 5.6 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is 61.88%.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/clorox-co-clx-holdings-trimmed-by-coastline-trust-co/1765485.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with Analyst Ratings Network's FREE daily email newsletter.